Pediatric Risk Factors for Infective Endocarditis
The highest-risk pediatric patients for infective endocarditis are those with complex cyanotic congenital heart disease who have undergone palliative or corrective cardiac surgery, particularly those with prosthetic valves, conduits, surgical shunts, or residual defects, followed by children with central venous catheters regardless of underlying cardiac anatomy. 1
Cardiac Risk Factors (Highest Priority)
Congenital Heart Disease - Surgical Status
The risk stratification for CHD has fundamentally shifted in the modern era. Approximately 50% of pediatric IE cases with CHD now occur in patients who have had previous cardiac surgery, particularly palliative shunt procedures or complex intracardiac repairs 1. This represents a critical evolution from historical patterns.
Highest-risk cardiac lesions include:
- Cyanotic CHD with repair/palliation - carries the highest annualized risk, especially with obstruction to pulmonary blood flow 1
- Prosthetic aortic valve replacement - cumulative incidence reaches 13.3% at 25 years in aortic valve stenosis patients 1
- Surgical shunts or prosthetic material - creates long-term IE risk, particularly with residual defects 1
- Endocardial cushion defects - adjusted OR 8.01 2
- Left-sided lesions - adjusted OR 4.36 2
- Ventricular septal defects - adjusted OR 2.93 2
Critical timing consideration: When prosthetic valves or conduits are used with persistent hemodynamic problems, IE risk is elevated even in the immediate postoperative period (first 2 weeks), unlike most defects where risk increases over time 1.
Transcatheter Devices
The increasing use of septal occluders, vascular occluders, and coils creates IE risk particularly in the early post-deployment period before endothelialization occurs. Residual defects after device placement amplify this risk 1.
Non-Cardiac Risk Factors
Central Venous Catheters (Major Risk Factor)
Central venous catheters represent the second most important risk factor and are increasingly responsible for IE in structurally normal hearts 1. This includes:
- Peripherally inserted central catheters (PICCs)
- Tunneled central venous catheters
- Long-term indwelling lines
Key epidemiologic shift: Currently 8-10% of pediatric IE develops without structural heart disease or other identifiable risk factors, typically involving aortic or mitral valves secondary to Staphylococcus aureus bacteremia from central lines 1. Recent data shows CVCs present in 62.5% of IE episodes, with higher prevalence in children with comorbidities beyond isolated CHD 3.
Neonatal-Specific Risk Factors
7.3% of pediatric IE cases occur in the first month of life 1. Neonatal risk factors include:
- Prematurity (31% of neonatal IE deaths) 1
- Central venous catheters for complex medical management
- Fewer than one-third of neonatal IE cases occur with congenital cardiac disease 1
- Right-sided heart involvement is more common due to indwelling lines 1
Invasive Procedures
Cardiac procedures significantly increase IE risk 2:
- Central venous catheter insertion (adjusted OR 3.17)
- Cardiac catheterization (adjusted OR 3.74)
- Open-heart surgery (adjusted OR 2.47)
- Valve surgery (adjusted OR 3.20)
- Shunt surgery (adjusted OR 7.43)
Important caveat: Dental procedures do NOT increase IE risk in pediatric CHD patients, regardless of antibiotic prophylaxis use 2. This contrasts with adult guidelines and should inform clinical decision-making.
Bacteremia Characteristics
Recent high-quality evidence identifies specific bacteremia patterns that predict IE 4, 5:
- Persistent bacteremia (>2 positive blood cultures) - strongly associated with IE 4, 5
- Staphylococcus aureus bacteremia - independent predictor; 8.8% of pediatric SAB cases develop endocarditis 4, 5
- Embolic or immunologic phenomena - independent predictor 4
Additional Risk Factors
- Protein-energy malnutrition - significantly associated with staphylococcal endocarditis 5
- Multidrug-resistant bacterial colonization - 30% of colonized children develop IE from the same MDRB strain 3
Factors NOT Associated with Increased Risk
Important clinical distinctions from adult IE:
- Congenital or acquired immunodeficiencies (without other risk factors) 1
- Intravenous drug abuse (not common in pediatrics) 1
- Degenerative heart disease 1
- Antimicrobial resistance alone 4
- Prior IE history 4
- Physical examination findings including murmurs (do not differentiate IE from non-IE) 4
Evolving Epidemiology
Critical trend: A 2-fold increase in IE incidence has been documented in recent years, driven primarily by increased numbers of CHD patients who have undergone prior cardiac surgery (67.4% in 2012-2020 vs 40% in 2002-2011) 6. Additionally, non-HACEK Gram-negative bacteria now represent a higher proportion of IE cases than historically reported (27.8% in recent series), suggesting evolving microbiology 3.
The mortality rate remains significant at 6.3-10.3%, with highest risk in infants (mean age 2.5 months for operative mortality) 1, 6.